noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Virginia Commonwealth University

Breaking the stigma: Future physicians learn to provide compassionate[...]
FAA - Federal Aviation Administration

Trump’s Transportation Secretary Sean P. Duffy Announces Milestone in[...]
CDC - Centers for Disease Control[...]

Interim Clinical Considerations for the Use of Seasonal Influenza[...]

Healthcare

Allogene Therapeutics Inc.

09/02/2026 | Press release | Distributed by Public on 09/02/2026 06:35

Management Change/Compensation (Form 8-K)

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b)

On August 31, 2026, Geoffrey Parker, the Executive Vice President and Chief Financial Officer and principal financial officer of Allogene Therapeutics, Inc. (the "Company"), provided notice of his retirement from the Company in all capacities, effective November 6, 2026.

Allogene Therapeutics Inc. published this content on September 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on September 02, 2026 at 12:35 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]